Company news

Adimmune Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Adimmune announces financail statements of 2022 second quarter.

August 12, 2022

Adimmune To announce the completion status of execution of the stock repurchase

August 9, 2022

The list of the newly elected 21st directors (including independent directors) of the Company

June 29, 2022

The Company's shareholders' meeting approved the release of non-compete restrictions on directors

June 29, 2022

The Company's board of directors re-elected Dr. Chan Chi-Hsien as the chairperson

June 29, 2022

Announcement of members of the Company's 3rd audit committee

June 29, 2022

Announcement of the board resolution to repurchase treasury shares

June 9, 2022

Resolution by the board of directors not to distribute dividends.

March 29, 2022

The board of directors approved the company's 2021 consolidated financial report.

March 29, 2022

Subject: Announcement of the approval of the Company's quadrivalent influenza vaccine from China's National Medical Products Administration

February 11, 2022

Change to the research and development officer of the company

January 26, 2022

Adimmune: 's Quadrivalent Flu Vaccine Approved by TFDA

May 10, 2017

Adimmune begins shipments to EU and Phase III trial in Europe

November 23, 2016

Successfully Places NT$1.5 BN Guaranteed Convertible Bonds

October 21, 2016

Decks